TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Exclusive breastfeeding relative rate at 1 month of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive breastfeeding relative rate at 4 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive breastfeeding relative rate at 6 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to achieve platelet count ≥50x10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Freedom from Major Adverse Respiratory and Cardiovascular Events (MARCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of clinician's diagnosis of pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to next psychiatric rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fractional Synthesis Rate (FSR) of tryptophan metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Residual volume/ Total lung capacity (RV/TLC) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced expiratory volume at first second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time From reversal to extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time From the end of surgery to reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with a history of tonsillectomy or adenoidectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Grade 2 and higher adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 and higher adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Related Serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical progression parameters during hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum endotoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak negative power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alpha power during standardized daily gait assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with diabetes and prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of distinct phenotypes of type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunoglobins G levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FEV1 (Forced expiratory volume in the first second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: absolute albumin values in g/l
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Haemoglobin (Hb) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent time Sensor in range of 70 mg/dL to 180 mg/dL, inclusive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose management indicator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of combined cryotherapy with intralesional HBV vaccine injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety of combined cryotherapy with intralesional HBV vaccine injection
Endpoint domain: Adverse events/effects
Primary endpoint: urea reduction rate (URR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Boston Carpal Tunnel Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participants With Plasmodium Falciparum (Pf) Infection Detected by Microscopic Examination
Endpoint domain: Adverse events/effects
Primary endpoint: Validation of Keratoconus Outcome Research Questionnaire (KORQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Clinical Cure at Test of Cure (TOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in Number of liver transplantations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Patient Reported Outcome Measures (PROMs, e.g. Epworth Sleepiness Scale)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Electroencephalography (EEG) Power spectrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electrocardiogram (ECG) R-R intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sudden death due to ventricular hypertrophy
Endpoint domain: Mortality/survival
Primary endpoint: Sudden death due to right bundle branch block
Endpoint domain: Mortality/survival
Primary endpoint: Sudden death due to repolarization pattern
Endpoint domain: Mortality/survival
Primary endpoint: Sudden death due to ST elevation
Endpoint domain: Mortality/survival
Primary endpoint: Trabecular BV/TV at distal radius of non-dominant arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Short term recurrence of hernia
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of heart failure hospitalization and cardiovascular mortality
Endpoint domain: Mortality/survival
Primary endpoint: Improving of blood urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Indoxyl sulfate assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improving of serum creatinine mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient satisfaction regarding feasibility of organisation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative burden of AoP
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Medication-Related Problem (MRP) Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity and reliability of Baby Preparation and Worry Scale (Baby-PAWS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in naming scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvement in pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: EEG derived sleepiness biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline blood tests at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes from baseline neurophysiological tests at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Report of severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of baseline serum PCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: postoperative pancreatic fistula (POPF) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients having intraoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients having short-term postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients having middle-term postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients having long-term postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: response to filling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative changes in cross-section diameter of rectus femoris muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in WOMAC Likert pain subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of subjects undergoing Target Lesion Revascularization (TLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Enumeration of T-bet+, CD4+, and CD8+ T-cells in TIL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Effort Expenditure for Rewards Task (EEfRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Digit Symbol Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Single Task Gait Speed Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAARMS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved CHF detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maximal displacement of the deltoid muscle after therapy compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in delay time of the deltoid muscle after therapy compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in contraction time of the deltoid muscle after therapy compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of composite end-point of myocardial infarction, stroke, heart failure and death
Endpoint domain: Mortality/survival
Primary endpoint: Covid-19 vaccine uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Satisfaction with the educational process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Preoperative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Validated FLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of VR surgical simulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Daily observed pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: objective sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective sleep
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hearing assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain subscore on the KOOS Survey
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Susceptibility to Vaping Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correlation of visible fragments with histologic diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lobene Stain Index of Stain Extent Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lobene Stain Index of Stain Area Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lobene Stain Index of Stain Composite Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of diarrhea in hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Management effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: N-terminal prohormone BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MGQOL 15 score (Myasthenia Gravis Quality Of Life)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: First pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meibomian Gland change in expressibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basal tear output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Weight-Bearing Pain (WBP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Weight-Bearing Pain (WBP) at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers related to medullary adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: salivary cortisol slopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pediatric Inventory for Parents (PIP)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative long-term quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Immunity to Covid-19 vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response between arms at T = 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in nociplastic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in function (JOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in function (NDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction levels of materials prepared with the digital mind map technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Survivability
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in the use of fiberoptic bronchoscope
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Costs associated with the use of VDLT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Costs associated with the use of cDLT and fiberoptic bronchoscope
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants approached and recruited to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who drop out of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Adverse Events and Serious Adverse Events recorded during the study
Endpoint domain: Adverse events/effects
Primary endpoint: Change on baseline Activated Clotting Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Phase locking value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phase lag Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrist Actigraphy - Objective Sleep Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale-Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale - fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep Richard-Campbell Sleep Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Relative mineral weight content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in Visual analogue scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of eligible patients approached for consent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants receiving their first protein supplementation within 72 hours of enrolment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with fistula recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Change in Health-related quality of life (HRQoL) as assessed by the EQ-5D-5L questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence rate of any adverse reactions/events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence severity of any adverse reactions/events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of abnormal blood biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ocular surface impression cytology results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General self efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability/usability of intervention
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: VascuQoL-6
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PROMIS (Patient Reported Outcomes Measurement Information System)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes Distress Screening Scale (DDS17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CHIKV SNA Seroresponse Rate at Day 22
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CHIKV SNA GMT at Day 22
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number and Percentage of Participants With a CHIKV SNA Titer at or Above Threshold Values at Days 8, 15, 22, and 57
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bucco/facial-palatal ridge thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of anti-varicella zoster virus (VZV) glycoprotein E (gE) antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline Maternal-Fetal Attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Self-Reported Smoking Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ST-segment variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PBS Score agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in TSPO Radiotracer Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The 30 Second Sit to Stand Test(30SSST) for lower limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in GI related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety Event Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of Polyphenols
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gray matter volume in fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: White matter volume in fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acute toxicity of carbon ion radiotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Change in level of serum HBsAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative delirium assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: RAND 36-Item Health Survey (RAND-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Abdominal Surgery Impact Scale (ASIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of Major Congenital Malformations in Live-Born Infants
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Still Births, Pre-Term, or Fetal Loss
Endpoint domain: Mortality/survival
Primary endpoint: Hip-Knee-Ankle (HKA) angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Beck Depression Inventory Depression sub-scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total sufentanil consumption postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Weeks patients continued in treatment during trial period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants that Dropout during the first 28 days of Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of negative urinary drug screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragmatic Excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life of patient
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Crepitus grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of all adverse events (AEs) within 0-30 days after each dose of vaccination
Endpoint domain: Adverse events/effects